9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Companies
/Healthcare
Teva- Pharmaceutical Industries Ltd
$37.49
▲ $1.30 (+3.59%) today
Markets closed · 5:05am ET
TEVA Coverage
Page 4
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
11:25am ET
Health and Healthcare
Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:40am ET
Health and Healthcare
Major Pharma Sees Rising Tide in Short Interest
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:35am ET
Health and Healthcare
Short Sellers Up the Ante in Big Pharma
The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More
The top analyst upgrades, downgrades and initiations on Monday included Agilent Technologies, Amazon.com, American Water Works, Crocs, Deere, General Electric, Gilead Sciences, Slack and Teva Pharmaceutical.
9:45am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
8:55am ET
Investing
5 Sizzling New Stocks Under $10 With Massive Implied Upside
Here are five more stocks for aggressive accounts looking to get share count leverage on companies that have sizable upside potential.
8:30am ET
Health and Healthcare
Short Sellers Seek Direction on Big Pharma
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:30am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray and Wells Fargo.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Alcon, Analog Devices, Big Lots, CACI, CenterPoint, Cree, Lyft, Teva, WellCare and More
The top analyst upgrades, downgrades and initiations seen on Monday included Alcon, Analog Devices, Big Lots, CACI, CenterPoint Energy, Cree, Lyft, Teva Pharmaceutical and WellCare Health Plans.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Citigroup, Comcast, Cypress Semi, Huya, Six Flags, Tesla, Teva, US Steel, Verizon, Zynga and More
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Citigroup, Comcast, Cypress Semiconductor, Huya, Six Flags, Tesla, Teva Pharmaceutical, U.S. Steel, Verizon Communications and Zynga.
8:50am ET
Health and Healthcare
Big Pharma Short Sellers Hike Their Bets
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.